Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Duloxetine Delayed-Release Capsules USP
6/27/2014 9:39:27 AM
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Duloxetine Delayed-Release Capsules USP 20 mg, 30 mg and 60 mg, a therapeutic equivalent generic version of CYMBALTA® (Duloxetine Delayed-Release Capsules) in the US market on June 26, 2014. Dr. Reddy’s ANDA is approved by the United States Food & Drug Administration (USFDA).
Help employers find you! Check out all the jobs and post your resume.
comments powered by